Comparing electroCore (NASDAQ:ECOR) and Electromed (NYSE:ELMD)

electroCore (NASDAQ:ECORGet Rating) and Electromed (NYSE:ELMDGet Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, valuation, analyst recommendations, risk and institutional ownership.


This table compares electroCore and Electromed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
electroCore -283.37% -55.20% -46.44%
Electromed 5.83% 6.99% 6.10%

Analyst Ratings

This is a summary of current recommendations and price targets for electroCore and Electromed, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
electroCore 0 0 3 0 3.00
Electromed 0 0 0 0 N/A

electroCore currently has a consensus target price of $1.73, suggesting a potential upside of 434.57%. Given electroCore’s higher probable upside, research analysts clearly believe electroCore is more favorable than Electromed.

Earnings and Valuation

This table compares electroCore and Electromed’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
electroCore $5.45 million 4.19 -$17.22 million ($0.27) -1.20
Electromed $35.76 million 2.97 $2.36 million $0.26 47.89

Electromed has higher revenue and earnings than electroCore. electroCore is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

electroCore has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

Institutional and Insider Ownership

18.9% of electroCore shares are held by institutional investors. Comparatively, 32.7% of Electromed shares are held by institutional investors. 13.8% of electroCore shares are held by company insiders. Comparatively, 26.7% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.


Electromed beats electroCore on 9 of the 13 factors compared between the two stocks.

About electroCore (Get Rating)

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

About Electromed (Get Rating)

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with's FREE daily email newsletter.